Schizophrenia expert David Castle suggests caution, especially regarding medication use
It has been suggested that one can “predict” schizophrenia at an individual level. Features posited as being part of these so-called ultra-high risk (UHR) criteria1 include risk factors (eg, a family history of schizophrenia), symptoms (eg, attenuated positive psychotic symptoms) and longitudinal trajectory (decline in functioning). Added to this, mostly, is the requirement that the individual be “help-seeking”, though this is a loose term and raises questions about pathways to care.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Yung AR, McGorry PD, McFarlane C, et al. Monitoring and care of young people at incipient risk of psychosis. Schizoph Bull 1996; 22: 283-303.
- 2. Fusar-Poli P, Bonoldi I, Yung AR, et al. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry 2012; 69: 220-229.
- 3. Carr V. Time to move on? Commentary on the early intervention in psychosis debate. ANZ J Psychiatry 2012; 46: 384-386.
- 4. Morrison AP, French P, Stewart SLK, et al. Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial. BMJ 2012; 344: e2233. doi: 10.1136/bmj.e2233.
- 5. Bechdolf A, Wagner M, Ruhrmann S, et al. Preventing progression to first-episode psychosis in early initial prodromal states. Br J Psychiatry 2012; 200: 22-29.
I currently receive payment as an advisory board member from: Lundbeck, Eli Lilly, Astra Zeneca, Pfizer and Janssen-Cilag.